Suppression of bone remodeling associated with long-term bisphosphonate treatment is mediated by microRNA-30a-5p

Oral bisphosphonates (BPs) are a first-line treatment for osteoporosis. It is becoming a hot topic to identify new indicators for the early prediction of therapeutic effects and adverse reactions during the long-term use of BPs. To determine whether microRNA (miRNA) expression is modulated by long-t...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xia, Xu, Ruisheng, Ye, Jun-Xing, Yuan, Feng-Lai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161941/
https://www.ncbi.nlm.nih.gov/pubmed/35412438
http://dx.doi.org/10.1080/21655979.2022.2060584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161941/
https://www.ncbi.nlm.nih.gov/pubmed/35412438
http://dx.doi.org/10.1080/21655979.2022.2060584

Ejemplares similares